PAX Paxman AB (publ)

6.742USD68.50 SEK · STO+3.16%Mkt Cap: 156.92M USDP/E: —

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized for…

Key Statistics

Company
Market Cap156.92M USD
Enterprise Value147.74M USD
Revenue (TTM)36.02M USD
Gross Profit20.55M USD
Net Income (TTM)-1.65M USD
Revenue/Share1.47 USD
Last Price6.742 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees151
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0009806284
Valuation
P/E (Trailing)—
P/E (Forward)16.71
PEG—
EV/EBITDA40.02
EV/Revenue4.10
P/S4.36
P/B3.82
EPS (TTM)-0.02 USD
EPS (Forward)0.40 USD
52W Range
4.03695% of range6.880
52W High6.880 USD
52W Low4.036 USD
Profitability
Gross Margin66.64%
Oper. Margin0.41%
EBITDA Margin10.25%
Profit Margin-5.33%
ROE-4.13%
ROA-3.49%
ROIC1.43%
ROCE1.01%
Growth
Revenue Growth40.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF727.10K USD
CapEx (TTM)2.31M USD
FCF Margin-8.67%
FCF Yield-1.99%
Net Debt-9.18M USD
Net Debt/EBITDA-2.49
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio4.45
Quick Ratio3.75
Book Value/Sh1.76 USD
Cash/Share0.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.449 USD
Upside (mean)+40.1%
Target Range8.760 USD – 10.14 USD
8.760+40.1% to mean10.14
# Analysts2
Ownership
Shares Out.23.27M
Float16.62M
Insiders35.51%
Institutions24.53%
Technical
SMA 506.282 (+7.3%)
SMA 2005.237 (+28.8%)
Beta0.51
S&P 52W Chg12.00%
Avg Vol (30d)16.83K
Avg Vol (10d)20.17K
Technical Indicators
RSI (14)63.2
MACD0.7383
MACD Signal0.3858
MACD Hist.+0.3526
BB Upper6.832 USD
BB Middle6.395 USD
BB Lower5.958 USD
BB Width13.67%
ATR (14)0.2599 USD
Vol Ratio (20d)5.04x

About Paxman (STO: PAX)

›

Paxman (STO: PAX) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 151 employees.

The shares were at 68.50 SEK on 19 November 2026, up 5.4% over 52 weeks. Its 52-week range is 41.00 SEK to 69.90 SEK: the price is 2.0% below the high and 67.1% above the low.

Its market capitalisation is 1.59B SEK.

Paxman reports return on equity of -4.1%, an operating margin of 0.4% and revenue up 40.3% year over year.

It holds more cash than debt, a net cash position of 93.26M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 96.00 SEK is 40.1% above the current price.